M05.50

Rheumatoid polyneuropathy occurring alongside rheumatoid arthritis, reported when the affected joint site is not specified in the clinical documentation.

Verified May 8, 2026 · 7 sources ↓

Status: Billable
Chapter: 13
Related CPT: 8
Region: General

Drawn from CDCICD10DataAAPCCMSNIH

Documentation tips

What should appear in the chart to support M05.50.

Source · Editorial brief grounded in 7 cited references ↓

Record positive rheumatoid factor or anti-CCP lab results explicitly — M05 codes require seropositivity; absence of lab documentation may force a downcode to M06.
Identify and document the affected joint site by name (e.g., right wrist, left knee) so a site-specific M05.5x code can be assigned instead of the unspecified M05.50.
Document the polyneuropathy separately as a confirmed extraarticular manifestation of RA, not merely a symptom — vague symptom language may not support M05.5x coding.
Note the results of nerve conduction studies or EMG if performed, as these support the polyneuropathy component of this combined diagnosis.
Confirm the RA diagnosis is from a rheumatologist or treating provider, not abstracted solely from a problem list — CMS risk-adjustment guidance requires clinical support beyond a problem list entry.

Related CPT procedures

Procedure codes commonly billed with M05.50. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

99213 $95.19

Established patient office or outpatient visit requiring 20–29 minutes of total time or low-complexity medical decision-making.

99214 $135.61

Office visit for an established patient requiring moderate-complexity medical decision making (MDM), or 30–39 minutes of total provider time on the date of service.

99215 $192.39

Highest-level office or outpatient E/M visit for an established patient, qualifying via high-complexity medical decision making or 40–54 minutes of total provider time on the date of service.

86200 View procedure details

86235 View procedure details

95900 View procedure details

95903 View procedure details

95904 View procedure details

Common coding pitfalls

The recurring mistakes coders make with M05.50 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

Defaulting to M05.50 when site is actually documented — if the chart specifies shoulder, wrist, knee, or any other joint, use the corresponding site-specific M05.5x code instead.
Using M05.50 for seronegative RA with polyneuropathy — M05 codes require documented positive rheumatoid factor; seronegative cases belong under M06.
Confusing M05.50 (unspecified site) with M05.59 (multiple sites) — if the patient has polyneuropathy affecting multiple documented joint sites, M05.59 is correct.
Failing to exclude M05 when the diagnosis is juvenile RA (use M08.-) or spine-only RA (use M45.-), both of which are hard Excludes1 exclusions under M05.
Assigning only M05.50 when additional extraarticular manifestations are documented — code each distinct organ involvement separately per ICD-10-CM tabular instructions.

Clinical context

Source · Editorial summary grounded in 7 cited references ↓

M05.50 captures the extraarticular manifestation of rheumatoid arthritis in which peripheral nerve involvement (polyneuropathy) accompanies seropositive RA, but the documentation does not specify which joint site is affected. Use it only when the provider documents both the polyneuropathy and the rheumatoid arthritis with rheumatoid factor, and no laterality or anatomical site is recorded. This is the unspecified-site fallback within the M05.5x subcategory.

The M05 category applies exclusively to rheumatoid arthritis confirmed by positive rheumatoid factor (seropositive RA). If rheumatoid factor status is not documented or is negative, M06 codes apply instead. M05.50 is excluded from use when the arthritis is juvenile (M08.-), rheumatic fever-related (I00), or involves the spine (M45.-). CMS recognizes M05.50 as supporting medical necessity for biomarker testing under the CMS Biomarkers Overview article (A56541), and it appears in the MIPS Quality Measure #178 RA denominator population.

When site is documented, always assign the specific site code instead of M05.50. For example, right shoulder involvement maps to M05.511, left wrist to M05.532, and multiple sites to M05.59. M05.50 should not be the default choice when a site can be identified — it is only appropriate when documentation genuinely omits site.

Sibling codes

Other billable codes under M05.5 (laterality / anatomic variants).

M05.59

Rheumatoid polyneuropathy w rheumatoid arthritis mult site

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 7 cited references ↓

01When is M05.50 the correct code instead of a site-specific M05.5x code?

M05.50 is correct only when the provider documents rheumatoid polyneuropathy with seropositive RA but does not specify which joint site is involved. If any site is named — shoulder, elbow, wrist, hand, hip, knee, ankle — use the corresponding site-specific code (e.g., M05.511 for right shoulder).

02Does M05.50 require positive rheumatoid factor documentation?

Yes. The entire M05 category is reserved for seropositive RA — confirmed by documented positive RF or anti-CCP testing. If rheumatoid factor status is negative or undocumented, the correct parent category is M06, not M05.

03Can M05.50 be used for rheumatoid arthritis of the spine with neuropathy?

No. Rheumatoid arthritis of the spine is excluded from M05 by a hard Excludes1 note — it codes to M45.-. M05.50 cannot be used when the arthritis is limited to the spine.

04Is M05.50 valid for juvenile rheumatoid arthritis with polyneuropathy?

No. Juvenile rheumatoid arthritis is coded to M08.- and is explicitly excluded from M05 by an Excludes1 note. Do not use M05.50 for pediatric RA diagnoses.

05Does M05.50 appear in CMS quality reporting programs?

Yes. M05.50 is included in the MIPS Quality Measure #178 (RA Functional Status Assessment) denominator, making it relevant for practices participating in value-based reporting for rheumatoid arthritis patients.

06What is the difference between M05.50 and M05.59?

M05.50 means the joint site affected by RA with polyneuropathy is unspecified in the documentation. M05.59 means polyneuropathy with RA is present at multiple documented sites. If the note lists more than one joint, use M05.59, not M05.50.

07Can M05.50 be used as a secondary code alongside other RA extraarticular manifestation codes?

Yes, when a patient has both polyneuropathy and another distinct extraarticular manifestation (e.g., rheumatoid vasculitis), each manifestation is coded separately. M05.50 can appear on the same claim as other M05.6x or M05.7x codes when documentation supports multiple distinct extraarticular findings.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

Mira AI Scribe

Mira AI Scribe captures the documented positive rheumatoid factor or anti-CCP result, the provider's explicit diagnosis of polyneuropathy as an RA manifestation, and any joint sites mentioned in the encounter note. When a specific site is named, the scribe flags a more precise M05.5x code rather than defaulting to M05.50 — preventing unspecified-site coding that can trigger payer specificity edits and risk-adjustment undercapture.

See how Mira captures M05.50 documentation